Thermo Fisher Scientific Inc (TMO) financials · P/E 37, rev $44.56B
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Thermo Fisher Scientific Inc (TMO) P/E 37, rev $44.56B.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $44.56B | $42.88B |
| Operating Income | $7.75B | $7.34B |
| Net Income | $6.70B | $6.33B |
| EPS (Diluted) | $17.74 | $16.53 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $110.34B | $97.32B |
| Current Assets | $28.71B | $22.14B |
| Cash & Equivalents | $9.85B | $4.01B |
| Inventory | $5.42B | $4.98B |
| PP&E | $10.56B | $9.31B |
| Total Liabilities | $56.94B | $47.74B |
| Current Liabilities | $15.19B | $13.33B |
| Short-term Debt | $3.53B | $2.21B |
| Long-term Debt | $39.17B | $31.07B |
| Total Debt | $35.85B | $29.06B |
| Shareholders' Equity | $53.41B | $49.58B |
| Retained Earnings | $59.16B | $53.10B |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | $7.82B | $8.67B |
| CapEx | $1.52B | $1.40B |
| Investing Cash Flow | -$4.05B | -$5.84B |
| Financing Cash Flow | $1.80B | -$6.79B |
| Dividends Paid | $636.0M | $583.0M |
| Net Change in Cash | $5.84B | -$4.06B |
| Free Cash Flow | $6.29B | $7.27B |
FAQ
What is TMO P/E and revenue?
Thermo Fisher Scientific Inc (TMO) P/E 37, rev $44.56B.
What is TMO revenue?
Thermo Fisher Scientific Inc last cached revenue is $44.56B (FY2025).
Is TMO profitable?
Thermo Fisher Scientific Inc last cached net income is $6.70B (FY2025).
What are TMO total assets?
Thermo Fisher Scientific Inc last cached total assets are $110.34B (FY2025).
What is TMO free cash flow?
Thermo Fisher Scientific Inc last cached free cash flow is $6.29B (FY2025).
Not investment advice. Cached statements, not a live tape.